Why Akers Biosciences Is Trading Higher Today

Akers Biosciences Inc AKER shares are trading higher on Monday.

The shares of several health care companies are trading higher as multiple vaccine companies issue data on the status of their ongoing trials.

Akers Biosciences is engaged in developing, manufacturing and supplying rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a time- and cost-efficient manner.

The pipeline products of the company focus on delivering diagnostic assistance in a variety of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious disease detection.

Akers Biosciences shares were trading up 15.68% at $5.09 during the time of publication on Monday. The stock has a 52-week high of $16.32 and a 52-week low of $1.55.